- Location
cancer monitoring
"-
Urine Is Developed by Trovagene
Nov 29, 2012US-based Trovagene has developed a urine-based molecular diagnostic test to detect and monitor cancer mutations. The test quantitatively detects KRAS mutations in transrenal DNA,which may be originated from both normal and diseased cells. ...
Tags: Trovagene, molecular diagnostic test, cancer mutations, cancer monitoring
-
Vermillion Has Received a Notice of Allowance
Apr 17, 2012Vermillion has received a notice of allowance from the United States Patent and Trademark Office for a patent entitled, Biomarkers for Ovarian Cancer. The patent makes claims in the uses of a urinary Small MBL-associated protein ...
